doi:10.19983/j.issn.2096-8493.20220162

Abstract

CLC Number:

References 17

[1]	World Health Organization. Global tuberculosis report 2022, Geneva: World Health Organization, 2022.
[2]	UNAIDS. IN DANGER: UNAIDS Global AIDS Update 2022. Geneva: Joint United Nations Programme on HIV/AIDS, 2022.
[3]	何纳. 中国艾滋病流行病学研究新进展. 中华疾病控制杂志, 2021, 25(12):1365-1368,1480. doi:10.16462/j.cnki.zhjbkz.2021.12.001. doi: 10.16462/j.cnki.zhjbkz.2021.12.001 URL
[4]	Liu E, Wang Q, Zhang G, et al. Tuberculosis/HIV Coinfection and Treatment Trends-China, 2015—2019. China CDC Wkly, 2020, 2(48):924-928. doi:10.46234/ccdcw2020.252. doi: 10.46234/ccdcw2020.252 URL
[5]	杨蕊, 许琳, 李玲. 2010—2020年云南省MTB/HIV双重感染流行特征分析. 结核与肺部疾病杂志, 2022, 3(6):437-442. doi:10.19983/j.issn.2096-8493.20220133. doi: 10.19983/j.issn.2096-8493.20220133 URL
[6]	罗丹, 陈松华, 张钰, 等. 2015—2021年浙江省MTB/HIV双重感染筛查现况及趋势分析. 结核与肺部疾病杂志, 2022, 3(6):443-448. doi:10.19983/j.issn.2096-8493.20220132. doi: 10.19983/j.issn.2096-8493.20220132 URL
[7]	李京, 何金戈, 李婷, 等. 四川省凉山彝族自治州结核病加强管理模式实施的可行性及有效性分析. 结核与肺部疾病杂志, 2022, 3(6):449-454. doi:10.19983/j.issn.2096-8493.202200152. doi: 10.19983/j.issn.2096-8493.202200152 URL
[8]	Maimaiti R, Zhang Y, Pan K, et al. High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China. BMC Infect Dis, 2017, 17(1):15. doi:10.1186/s12879-016-2152-4. doi: 10.1186/s12879-016-2152-4 URL pmid: 28056848
[9]	黄威, 沈银忠. 艾滋病合并结核病诊治中的关键问题. 结核与肺部疾病杂志, 2022, 3(6):431-436. doi:10.19983/j.issn.2096-8493.20220156. doi: 10.19983/j.issn.2096-8493.20220156 URL
[10]	WHO consolidated guidelines on tuberculosis. Module 3: diagnosis-rapid diagnostics for tuberculosis detection, 2021 update.Geneva: World Health Organization, 2021.
[11]	World Health Organization. WHO consolidated guidelines on tuberculosis Module 1: prevention tuberculosis preventive treatment. Geneva: World Health Organization, 2020.
[12]	中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020 年版)的通知.国卫办疾控函〔2020〕279号. 2020-04-02.
[13]	刘二勇, 成诗明, 赖钰基, 等. 结核病预防性治疗研究进展. 中国防痨杂志, 2014, 36(1):59-63. doi:10.3969/j.issn.1000-6621.2014.01.013. doi: 10.3969/j.issn.1000-6621.2014.01.013 URL
[14]	曹雪芳, 何勇鹏, 高磊. HIV/AIDS人群结核分枝杆菌感染和预防性治疗研究进展. 结核与肺部疾病杂志, 2022, 3(6):511-516. doi:10.19983/j.issn.2096-8493.20220155. doi: 10.19983/j.issn.2096-8493.20220155 URL
[15]	沈鑫, 沙巍, 刘剑君. 新型冠状病毒肺炎疫情对结核病防控的影响及对策. 中国防痨杂志, 2020, 42(6):544-548. doi:10.3969/j.issn.1000-6621.2020.06.003. doi: 10.3969/j.issn.1000-6621.2020.06.003 URL
[16]	中华人民共和国中央人民政府. 中共中央国务院印发《“健康中国2030”规划纲要》[EB/OL].[2022-10-08]. http://www.gov.cn/xinwen/2016-10/25/content_5124174.htm.
[17]	国家卫生健康委员会. 健康中国行动(2019—2030年)[EB/OL].[2022-10-08]. http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 17

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yang Shuqi, Li Feng. Advances in PD1/PD-L1 inhibitors in tuberculosis research [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 94-101.
[2]	Zhang Ying, Guo Chunhui. Research progress in the treatment of tuberculous tracheobronchial stenosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 87-93.
[3]	Yan Wenhua, Chen Wenjun. The value of digital health education in the preventive management of caregivers of patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 73-78.
[4]	Gu Jinhua, Zhang Panpan. Evaluation of the application value of three detection methods for Mycobacterium tuberculosis in a comprehensive hospital [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 68-72.
[5]	Yan Qinghu, Xue Feng, Yu Yong, Qin Yi, Yan Qingmei, Cui Jia. The value of ultrasound-guided microwave ablation in the treatment of localized tuberculous lesions [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 55-60.
[6]	Qi Wei, Zhao Enyi. The epidemic characteristics and the trends of pulmonary tuberculosis in elderly and non-elderly in central urban area, Tianjin from 2006 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 46-54.
[7]	Yang Yan, Dong Wen, Chen Jianjun, Zhang Yu. Epidemiologic characteristics of pulmonary tuberculosis in Zhuxi County, Shiyan City (2014-2023) [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 40-45.
[8]	Zheng Jianli, Wu Yumei, Zhang Shili, Du Zixian, Li Turong, Chen Shisheng, Lin Wenge. Cost-effectiveness analysis of active tuberculosis screening among high-risk populations in Longyan City, Fujian Province [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 35-39.
[9]	Zhao Yongnian, Zhang Lijie, Wang Tongmin. Analysis of the epidemiological characteristics of reported pulmonary tuberculosis in Xinjiang Production and Construction Corps, 2014—2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 30-34.
[10]	Wan Ying, Pang Xuewen, Zhang Fan. Evaluation on effect of health promotion for tuberculosis prevention and control in Tianjin City from 2010 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 22-29.
[11]	Chen Yu, Li Xiaorui, Wang Miaoran, Zhang Yuqi, Liu Chang, Wang Zhaohua, Shi Jie, Fan Lichao, Yin Zhihua, Xie Jianping. The research progress on the role of metal ions in tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 102-112.
[12]	Chen Jing, Qin Yali, Wang Mingdong, Yang Rubin, Wang Qian, Peng Yanqing, Qiu Jiyao, Zhang Xiao, Zhou Xinai. The value of QuantiFERON-TB Gold Plus in the clinical diagnosis of active pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 61-67.
[13]	Liao Ying, Pang Yan, Zhao Jing, He Gaoqin, You Maolin, Wang Lei. Analysis on the reporting and case finding delay characteristics of pulmonary tuberculosis patients in Liangping District, Chongqing from 2018 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 8-13.
[14]	. [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 495-499.
[15]	Hu Xinyang, Gao Jingtao. Interpretation of WHO global tuberculosis report 2024 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 500-504.